Lenvatinib

SI-1588

Lenvatinib, 98%

CAS No. : [417716-92-8]

MDL No. : MFCD16038644

Synonyms : E7080

IUPAC Name : 4-(3-Chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide

Price And Availability
Pack Size	Price in USD	Add To Shopping Cart	Availability	Shipping Status
5MG	50.00		In Stock	Estimated to ship on 20 September 2026
10MG	70.00		In Stock	Estimated to ship on 20 September 2026
50MG	150.00		In Stock	Estimated to ship on 20 September 2026
100MG	225.00		In Stock	Estimated to ship on 20 September 2026

Applications : Lenvatinib is an oral, multi-targeted tyrosine kinase inhibitor with IC50s of 4 and 5.2 nM for VEGFR2(KDR) and VEGFR3(Flt-4), respectively. Lenvatinib is less potent against VEGFR1/Flt-1 and shows approximately 10-fold selectivity for VEGFR2/3 over FGFR1, PDGFRα/β.

References : Matsui J. et al.: Int. J. Cancer 122(3), 664-671, 2008; Matsui J. et al.: Clin Cancer Res., 14(17), 545, 2008; Glen H. et al.: BMC Cancer 11, 309, 2011.

Storage : Keep container tightly closed under nitrogen or argon and refrigerate for long-term shelf life.

Caution : In case of contact with skin or eyes, rinse immediately with plenty of water and seek medical advice. Wear suitable protective clothing and gloves.